<DOC>
	<DOCNO>NCT01380665</DOCNO>
	<brief_summary>The intent study evaluate Prevena ™ 125 Unit dress system , apply either hip knee area surgical cut time hospitalize .</brief_summary>
	<brief_title>Prevena™ Incision Management System Over Primarily Closed Hip Knee Incisions Patients Immediately Post Total Hip Knee Arthroplasty</brief_title>
	<detailed_description />
	<criteria>1 . Subject must ≥ 18 year age 2 . Subject must , treat physician 's determination definition , appropriate Candidate primary total hip knee arthroplasty 3 . Subjects undergo primary total knee hip arthroplasty must linear semilinear incision whose length curvature fit within dimension bound polyurethane foam ( 10 inch length 2.5 inch width ) 4 . Subject able willing provide write informed consent comply visit schedule 5 . Subject must agree avoid application tan lotion exposure ultraviolet radiation sun artificial source tan bed operative area duration study participation 6 . Subject must pregnant childbearing potential , otherwise must surgically sterilize unable conceive . All female , regardless childbearing potential , receive urine hCG test 2 week prior surgery test result must negative pregnancy . 7 . Subjects childbearing potential must utilize acceptable method birth control ( eg , birth control pill , condom spermicide , diaphragm spermicide , implant , IUD , injection , vaginal ring , hormonal skin patch , etc ) willing continue birth control duration study participation . If birth control method form birth control pill , shot , implant skin patch , IUD , method must utilize least 30 day prior study participation . 8 . Subject must willing wear loose fit clothing duration treatment period 9 . Subject must willing comply visit schedule duration study 1 . Positive pregnancy test confirm hCG urine 2 . Current past ( 30 day prior surgery ) within time screen attempt become pregnant 3 . Current local systemic infection ( eg , skin infection , sinus infection , urinary tract infection , sepsis , etc ) 4 . Current past ( 14 day prior surgery ) within time screen topical treatment operative area ( eg , laser hair tattoo removal , sunless tan lotion ) 5 . Current past ( 14 day prior surgery ) steroid topical therapy operative area 6 . Current past ( 30 day prior surgery ) use oral steroid ( NOTE : Use nontopical , ophthalmic aerosol type steroid ( ie , inhaled corticosteroid ) permit screen throughout clinical trial ) 7 . Current past ( 72 hour prior surgery ) within surgery use antihistamines 8 . Current past ( 30 day prior surgery ) within time screen use oral Tetracycline AcutaneTM topical Tetracycline AcutaneTM operative area 9 . Presence skin lesion abnormality operative area 10 . Current past malignancy require immunosuppressant therapy chemotherapy within 5 year within time screen 11 . Presence excessive skin fold operative area 12 . Intentional exposure operative area ultraviolet radiation ( 14 day prior surgery ) within time screening ( ie , sunbathe tan bed ) 13 . Presence sunburn peel skin operative area 14 . Tattoos operative area 15 . Presence severe , raise scar tissue operative area may interfere pre post skin evaluation assessment 16 . Presence open wind prior index surgical procedure operative area 17 . Reported alcohol ( ≥ 3 drink per day ) drug abuse within past 6 month 18 . Topical hypersensitivity allergy disposable component dress system ( eg , silver , polyurethane , polyester , acrylic adhesive ) 19 . Topical hypersensitivity allergy towards medical adhesive 20 . Current enrollment past participation clinical study study within ≤30 day 21 . Any systemic local active dermatological disease might interfere evaluation operative area ( eg , Meleney 's ulcer , scleroderma , chronic urticaria , psoriasis , skin cancer , eczema , seborrhea , malignancy ) 22 . Connective tissue disease collagen vascular disease ( eg , EhlersDanlos syndrome , systemic lupus erythematosus , rheumatoid arthritis ) 23 . Current history hematological disorder condition ( eg , polycythemia vera , thrombocythemia , sicklecell disease ) 24 . Any Subject condition potentially result abnormally pigment skin ( eg , melasma , vitiligo , pityriasis versicolor ) 25 . Inability refusal wear loose fit clothing duration treatment period 26 . Subjects orthopaedic reconstruction require addition total hip knee arthroplasty 27 . Subjects total hip knee arthroplasty result acute orthopaedic trauma 28 . Subjects incur acute orthopaedic trauma ( ie , hip fracture ) recently time 29 . Subjects either acute chronic open/active wound present ( include biopsy , ulceration , etc ) 30 . Subjects index procedure revision total hip knee arthroplasty 31 . Subjects primary partial total hip knee arthroplasty would also perform contra lateral knee hip time</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Prevena</keyword>
	<keyword>Incision</keyword>
	<keyword>Management</keyword>
	<keyword>System</keyword>
	<keyword>total</keyword>
	<keyword>knee</keyword>
	<keyword>hip</keyword>
	<keyword>replacement</keyword>
	<keyword>Surgery</keyword>
	<keyword>Negative</keyword>
	<keyword>Pressure</keyword>
	<keyword>dress</keyword>
	<keyword>KCI</keyword>
</DOC>